The formation of antigonadotrophic substances have resulted from the prolonged administration of all the gonadotrophins which have been studied. Though for some time it was supposed that antihormones were not formed against homologous gonadotrophins, Katzman et al. (1947) (Rowlands, 1937;  Thompson, 1937; Katzman et al., 1947; Marvin & Meyer, 1943) ; further, a given sample of serum may augment at low dosages and inhibit if higher levels of the serum are administered with the gonadotrophin.
Sera from certain patients who have not been treated with gonadotrophins have the capacity to inhibit the response to gonadotrophins (Collip, 1935) . Con¬ versely, Rowlands (1938 a) reports that the sera of some untreated animals have capacity to augment the response to gonadotrophins, but he interpreted this to nonspecific augmentation even though the materials were injected on oppo¬ site sides. Whether the substances in the serum of untreated individuals responsible for these inhibiting or augmenting responses have any relation to the substances formed by continued injection of gonadotrophins is unknown. The fact that antigonadotrophins are not found in the blood serum of the mare (Cole, 1946) , or in the blood of women after parturition (Sitlman, 1937) Table 5 in which antisera from rabbits treated chronically with PMS were used. One ml. of these antisera were able to completely inactivate 15 I.U. of PMS. It appears from these tests that the amount of precipitating antibodies in these sera was very low. The ability to precipitate crude horse serum was less than for the PMS extract. Relationship between anti-and progonadotrophins.
A number of investigations have indicated that the presence of antigonado¬ trophins in the sera of animals chronically treated with gonadotrophin is pre¬ ceded by a period in which the serum will augment the gonadotrophic response (Thompson, 1937; Marvin 8c Meyer, 1943; Katzman et al, 1947) . Furthermore , it has been demonstrated that certain antisera will either augment or inhibit the response to gonadotrophin depending on the dosage of antiserum or upon the type of gonadotrophin administered (Rowlands, 1937; Katzman et al, 1947; McShan et al, 1943; 0stergaard, 1942 (Fig. 1) (Ostergaard, 1942 
